Both in Pharmaceuticals
Xenon Pharmaceuticals vs Amylyx Pharmaceuticals
Over the past year XENE returned −4.8% and AMLX returned +110.8%; their daily moves had a correlation of 0.22.
XENE −4.8% AMLX +110.8%Growth of $1, one year, split-adjusted
| Metric | XENE | AMLX |
|---|---|---|
| Price | $39.14 | $28.68 |
| Market cap | $3.79B | $3.60B |
| Today | +2.38% | −1.80% |
| 1 month | +7.0% | +2.3% |
| 6 months | −33.2% | +78.5% |
| Year to date | −12.7% | +137.4% |
| 1 year | −4.8% | +110.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $930.7M | $250.8M |
| Dividend yield | — | — |
| Volatility (60d) | 82.6% | 112.3% |
| Short % of float | 8.1% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).